Energy Efficiency, GHG Emissions, Industrial  -  March 22, 2024

Fresenius Medical Care Lowers Emissions by 16%

Fresenius Medical Care, a provider of products and services for individuals with renal diseases, announced its Scope 1 and 2 emissions decreased by 16% from a 2020 baseline. 

The company’s recent submission of the commitment letter to the Science Based Targets Initiative (SBTi) highlights its goal to achieve climate neutrality in operations by 2040, which is in line with the Paris Agreement.

Fresenius Medical Care achieved progress in line with its climate target roadmap and expanded its environmental reporting as the company works toward reducing its environmental footprint. 

Details were published in its joint 2023 Annual Report and Non-financial Group Report.

"The year 2023 was a transformative one for Fresenius Medical Care, as we set out to achieve important structural, operational, and cultural changes,” said Helen Giza, CEO and Chair of the Management Board of Fresenius Medical Care AG, in a statement. “I am proud to say that we successfully executed on our commitment of fundamental transformation and made significant progress against our financial and sustainability targets in our strategic plan."

Read These Related Articles:

• Fresenius Medical Care Signs 5 Solar/Wind PPAs
• Fresenius Medical Care Commits to 2040 Climate Neutrality

Share this valuable information with your colleagues using the buttons below: